At the Food and Drug Administration, the physician and venture investor promoted policies focused on innovating approaches to population health, opioids, chronic disease, AI and precision medicine.
Rush said info. could include names, addresses, dates of birth, and insurance information but not treatment, diagnosis or personal financial information.
There’s pent-up demand to get into the model that qualifies as an advanced APM under MACRA, but first providers want to see if other participants are staying in.